CT

The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.

Latest News

What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer

By Jeff Hall

January 29th 2025

For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.

Multimodal AI with CCTA and MRI Data Shows Promise in Predicting MACE in Patients with Obstructive CAD

By Jeff Hall

January 29th 2025

Study: Contrast-Enhanced Ultrasound May Improve LI-RADS Assessment of High-Risk Indeterminate Liver Lesions

By Jeff Hall

January 23rd 2025

Study: CT-Based AI Offers Enhanced Sensitivity and Reduced Segmentation Time for Lung Tumors

By Jeff Hall

January 21st 2025

Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging

By Jeff Hall

January 20th 2025

Latest CME Events & Activities

21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 8, 2025

Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

26th Annual International Lung Cancer Congress®

July 25-26, 2025

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure